Low molecular weight heparin prevents activation of coagulation in a hypobaric environment

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 5, 2001, Pages 371-374

  Bendz, Bjørn ^a   Sevre, K ^a   Andersen, T O ^a   Sandset, P M ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anti activated factor X activity; Hypobaric hypoxia; Low molecular weight heparin; Prothrombin fragments 1 + 2; Thrombin antithrombin complex; Thromboprophylaxis; Tissue factor pathway inhibitor; Travel

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AIRCRAFT; ARTICLE; DRUG EFFECT; HUMAN; HYPOBARISM; HYPOXIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS;

EID: 0034897486     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200107000-00006     Document Type: Article

References (18)

1. Venous thromboembolism in association with prolonged air travel
2. The economy class syndrome - A survey of 19 cases
3. Acute pulmonary embolism following air travel
4. Air travel and thrombotic episodes: The economy class syndrome
5. Surgery and environmental influence as risk factors for the development of deep vein thrombosis in animal experiments
6. Travel as a risk factor for venous thromboembolic disease: A case control study
7. Travel and risk of venous thrombosis
8. Association between acute hypobaric hypoxia and activation of coagulation in human beings
9. Altitude exposures during aircraft flight. Flying higher
10. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
11. An enzyme linked immunosorption assay for tissue factor pathway inhibitor
12. Dose dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
13. To help prevent circulatory problems on long trips
14. Risk factors and thrombosis after airline flight
15. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
16. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
17. Prevention of venous thromboembolism in internal medicine with unfractionated heparin or low-molecular-weight heparins: A meta-analysis of randomised clinical trials
18. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial